Reliance Industries, through its subsidiary Reliance Strategic Business Ventures, has acquired oncology-focused healthcare platform Karkinos for Rs 375 crore. The acquisition aims to enhance Reliance's health services portfolio, with Karkinos providing innovative cancer detection and treatment solutions. Prominent past investors included Tata Sons and Mayo Clinic.
